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Abstract
Background: The cell adhesion molecule integrin α4β7 helps direct the migration of blood
lymphocytes to the intestine and associated lymphoid tissues. We hypothesized that β7+ and β7-
blood memory T helper cells differ in their expression of genes that play a role in the adhesion or
migration of T cells.
Results: RNA was prepared from β7+ and β7- CD4+ CD45RA- blood T cells from nine normal
human subjects and analyzed using oligonucleotide microarrays. Of 21357 genes represented on
the arrays, 16 were more highly expressed in β7+ cells and 18 were more highly expressed in β7-
cells (≥1.5 fold difference and adjusted P < 0.05). Several of the differentially expressed transcripts
encode proteins with established or putative roles in lymphocyte adhesion and chemotaxis,
including the chemokine receptors CCR9 and CCR10, the integrin α4 subunit, L-selectin, KLRB1
(CD161), NT5E (CD73), LGALS1 and LGALS2 (galectin-1 and -2), and RGS1. Flow cytometry was
used to determine whether differences in levels of transcripts encoding cell surface proteins were
associated with differential expression of those proteins. Using this approach, we found that surface
expression of KLRB1, LAIR1, and NT5E proteins was higher on β7+ memory/effector T cells than
on β7- cells.
Conclusions:  Memory/effector T cells that express integrin β7 have a distinct pattern of
expression of a set of gene transcripts. Several of these molecules can affect cell adhesion or
chemotaxis and are therefore likely to modulate the complex multistep process that regulates
trafficking of CD4+ memory T cell subsets with different homing behaviors.
Background
Lymphocyte migration is a multistep process that involves
a complex interplay between adhesion molecules and
chemokines and their G protein-coupled receptors [1,2].
Naïve T cells express the adhesion molecule L-selectin, the
chemokine receptor CCR7 and other molecules that allow
these cells to migrate preferentially to secondary lym-
phoid organs where they can encounter antigen-present-
ing cells. When presented with appropriate antigens, these
T cells can differentiate into memory T cells. Some mem-
ory cells continue to express L-selectin and/or CCR7 and
to migrate efficiently to secondary lymphoid organs,
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whereas others lose expression of these molecules and
instead express other molecules that direct migration (or
"homing") to other organs [1,2].
Extensive investigation has helped to define the role of
some adhesion molecules and chemokine receptors in
CD4+ memory T cell homing to the skin and the gut. The
adhesion molecule cutaneous lymphocyte antigen (CLA)
and the cutaneous T cell-attracting chemokine receptor
CCR10 help control T cell homing to the skin [3-8]. The
adhesion molecule integrin α4β7 and the chemokine
receptor CCR9 play key roles in homing of lymphocytes to
the intestine and Peyer's patches [9-13]. Integrin α4β7 is a
receptor for mucosal addressin cell adhesion molecule-1
(MAdCAM-1), a glycoprotein that is expressed by gut
endothelium. CCR9 is a receptor for the chemokine TECK
(CCL25), which is expressed by endothelial cells and
other cells in the small intestine [14,15]. The adhesion
molecule and chemokine receptor expression pattern of
memory/effector CD4+ T cells is strongly influenced by
whether initial T cell activation takes place in cutaneous or
intestinal lymph nodes [16-18]. Recent evidence suggests
that T cell homing receptor expression patterns are
"imprinted" by dendritic cells during antigen presentation
[19-21]. Although many other molecules have been
shown to help control lymphocyte adhesion or migration,
it is not clear which if any of these are selective expressed
in gut homing memory CD4+ T cells.
We used DNA microarrays to systematically compare RNA
transcript expression in human blood β7+ and β7- CD4+
memory T cells. We identified a substantial number of dif-
ferentially expressed genes, many of which have been pre-
viously shown to have effects on cell adhesion and
migration. In addition, we showed that some of these
transcript expression differences were reflected in differ-
ences in surface expression of the encoded proteins.
Results
Microarray analysis of differential gene expression by β7+ 
and β7- CD4+ memory T cells
As previously reported [22], human blood CD4+ T cells
could be divided into three distinct subsets based upon
their surface expression of integrin β7 and the naïve cell
marker CD45RA (Fig. 1A). CD45RA+ naïve cells expressed
low levels of β7. CD45RA- memory T cells were divided
into a larger population of β7- cells and a smaller popula-
tion of β7+ cells. The integrin β7 subunit can combine
with either integrin α4 (to form the gut homing receptor
α4β7) or αE. Integrin αEβ7 is highly expressed on gut
intraepithelial lymphocytes but is rarely expressed by
blood T cells and its possible role in homing is less clear
[23-25]. Consistent with previous reports [22,23,26],
staining with antibodies specific for the α4β7 and αEβ7
complexes (Act-1 and HML-1 respectively) showed that
the virtually all β7-expressing CD4+ T cells in the blood
were α4β7+ , and that only 0.5 ± 0.3% (mean ± SD) of
blood CD4+ T cells expressed αEβ7. We were able to
obtain highly purified populations of β7+ and β7- CD4+
CD45RA- cells by flow cytometric sorting (Fig. 1B and
1C).
We used DNA microarrays to compare RNA transcript
expression by β7+  and  β7-  cells from 9 healthy adult
human subjects. Using this approach, we identified 16
genes that were expressed at higher levels in β7+ cells (at
least 1.5-fold higher expression and P < 0.05 when
adjusted for multiple comparisons). These are listed in
Table 1. Our estimates of fold difference are likely to be
conservative since the use of amplified RNA (as opposed
to unamplified cDNA) tends to underestimate fold differ-
ences [27]. The most highly differentially expressed tran-
script encodes the chemokine receptor CCR9. CCR9
protein has previously been shown to be preferentially
expressed on α4β7+ blood CD4+ T cells [13]. The ITGA4
transcript encodes the α subunit of integrin α4β7, and was
expressed at 1.7-fold higher levels on β7+ cells. Other
genes listed in Table 1 include genes encoding cell surface
receptors (LRRN3, CD1C, KLRB1, LAIR1, IL18RAP,
KLRG1), transcription factors (RAM2, SREBF1) and a
transcriptional repressor known to play a role in T cell dif-
ferentiation (GFI1). A complete listing of all gene expres-
sion results is provided in Appendix 2 [see additional file
2].
We also identified 18 gene transcripts that were expressed
at significantly lower levels in β7+ cells compared with β7-
cells (at least 1.5 times lower and adjusted P < 0.05).
These are listed in Table 2. GPR2, the most highly differ-
entially expressed transcript, encodes CCR10, the receptor
for the cutaneous T cell attracting chemokine (CTACK/
CCL27). Hudak et al. [8] found that CCR10 protein was
present on a subset of CD4+ CD45RA- T cells that express
the skin homing receptor CLA but do not express integrin
α4β7. We also found that β7- cells expressed more tran-
script for SELL, which encodes L-selectin (CD62L), a non-
integrin cell adhesion molecule that mediates lymphocyte
adhesion to peripheral lymph node high endothelial
venules. None of the other genes listed in Table 2 have
established roles in organ-specific homing, although both
RGS1 and LGALS1 have been reported to modulate lym-
phocyte adhesion (see Discussion). Given the importance
of G protein-coupled receptors in regulating leukocyte
migration, we note that in addition to GPR2/CCR10, one
other G protein-coupled receptor, P2RY5, was expressed
at higher levels on β7- cells. Although classified as a purin-
ergic receptor, expression of P2RY5 did not result in nucle-
otide-evoked signaling responses, and the function of this
receptor remains unknown [28].BMC Immunology 2004, 5:13 http://www.biomedcentral.com/1471-2172/5/13
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Comparison of surface protein expression on β7+ and β7- 
CD4+ memory T cells
We wished to determine whether differences in expression
of selected transcripts were reflected in differences in
expression of the cell surface proteins encoded by those
transcripts. As previously discussed, the products of the
two most highly differentially expressed genes (CCR9 and
GPR2/CCR10) have already been shown to be highly
selectively expressed on α4β7+ and  α4β7- CD4+ T cells
respectively [8,13]. We selected four other cell surface pro-
teins encoded by transcripts that were expressed more
highly on β7+ cells for further analysis based upon the
availability of suitable antibodies. Three of these (LAIR1,
KLRB1, and KLRG1) are listed in Table 1. A fourth, NT5E
(ecto-5'-nucleotidase, also known as CD73), was also
significantly higher in β7+  cells (adjusted P < 0.01),
Integrin β7 expression on blood T helper cells and on purified β7- and β7+ memory T helper cell subsets Figure 1
Integrin β7 expression on blood T helper cells and on purified β7- and β7+ memory T helper cell subsets. Dot 
density plots depicting expression of the naïve cell marker CD45RA and integrin β7 on CD4+ blood T cells (A) and on purified 
β7+ (B) and β7- (C) memory cells in arbitrary fluorescence units. Sorted populations were ~99% pure. Quadrant markers indi-
cate settings used to sort populations based on CD45RA and β7 expression. Colors indicate the relative frequency of cells 
(from lowest to highest density: green, purple, light blue, orange, dark blue, and yellow).
Table 1: Gene transcripts with higher expression in β7+ versus β7- CD4+ CD45RA- T helper cells*
Symbol Name Accession Fold Difference P value
CCR9 chemokine (C-C motif) receptor 9 NM_031200 +3.0 < 0.01
CCL5 chemokine (C-C motif) ligand 5 NM_002985 +2.4 < 0.01
RAM2 transcription factor RAM2 NM_018719 +2.2 < 0.01
LRRN3 leucine rich repeat neuronal 3 AL442092 +2.1 < 0.01
GFI1 growth factor independent 1 NM_005263 +1.8 < 0.01
ITGA4 integrin, alpha 4 (CD49D) NM_000885 +1.7 < 0.01
CD1C CD1C antigen, c polypeptide NM_001765 +1.7 < 0.01
KLRB1 killer cell lectin-like receptor subfamily B, member 1 NM_002258 +1.7 < 0.01
LAIR1 leukocyte-associated Ig-like receptor 1 NM_002287 +1.7 < 0.01
RRM2 ribonucleotide reductase M2 polypeptide NM_001034 +1.6 < 0.01
-- Homo sapiens cDNA FLJ32290 fis, clone PROST2000463 AK056852 +1.6 < 0.01
HHL expressed in hematopoietic cells, heart, liver NM_014857 +1.6 0.02
IL18RAP interleukin 18 receptor accessory protein NM_003853 +1.6 < 0.01
SREBF1 sterol regulatory element binding transcription factor 1 NM_004176 +1.6 < 0.01
KLRG1 killer cell lectin-like receptor subfamily G, member 1 NM_005810 +1.5 < 0.01
LGALS2 lectin, galactoside-binding, soluble, 2 (galectin 2) NM_006498 +1.5 0.01
* Includes all transcripts with fold difference ≥+1.5 and adjusted P < 0.05. Positive fold difference values indicate higher expression on β7+ cells.
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although the estimated magnitude of the difference was
smaller (1.3-fold). We used flow cytometry to measure
expression of each of these four molecules on CD4+ T cell
subsets from human blood. For comparison, we also ana-
lyzed surface expression of one protein (SELL/CD62L)
encoded by a transcript that was expressed at higher levels
on β7- cells. We used a different population of study sub-
jects from that used in the microarray studies to ensure
that our findings could be validated in an independent
sample. For four of the five proteins examined, the extent
of differential surface expression was at least as great as
predicted from the microarray data (Table 3). The other
protein, KLRG1, was not consistently differentially
expressed.
We used flow cytometry to conduct a more detailed anal-
ysis of the expression of KLRB1, NT5E and LAIR1 on T
helper cell subsets with distinct homing properties. A
small subset of memory cells expressed the skin homing
receptor CLA (~4% of CD4+ CD45RA- T cells). These CLA+
cells had low expression of KLRB1, NT5E and LAIR1 (sim-
ilar to levels found in other β7- CD45RA- cells, data not
shown). The adhesion molecule L-selectin (SELL, CD62L)
and the chemokine receptor CCR7 both play roles in
homing to secondary lymphoid organs and each is
Table 2: Gene transcripts with higher expression in β7- versus β7+ CD4+ CD45RA- T helper cells*
Symbol Name Accession Fold Difference P value
GPR2 G protein-coupled receptor 2 (CCR10) NM_016602 -3.2 < 0.01
RGS1 regulator of G-protein signalling 1 NM_002922 -2.0 < 0.01
TRIM2 tripartite motif-containing 2 NM_015271 -1.9 < 0.01
C1orf24 chromosome 1 open reading frame 24 NM_052966 -1.9 < 0.01
CAMTA1 calmodulin binding transcription activator 1 AB020640 -1.9 < 0.01
LMNA lamin A/C NM_005572 -1.9 < 0.01
LGALS1 lectin, galactoside-binding, soluble, 1 (galectin 1) NM_002305 -1.9 < 0.01
P2RY5 purinergic receptor P2Y, G-protein coupled, 5 NM_005767 -1.8 < 0.01
SELL selectin L (lymphocyte adhesion molecule 1) NM_000655 -1.8 0.02
-- similar to RIKEN cDNA 1700007B22 AK021437 -1.8 < 0.01
ChGn chondroitin beta1,4 N-acetylgalactosaminyltransferase NM_018371 -1.8 < 0.01
-- similar to BcDNA:GH11415 gene product AK056276 -1.7 < 0.01
PTPLA protein tyrosine phosphatase-like, member a NM_014241 -1.7 < 0.01
MRC2 mannose receptor, C type 2 NM_006039 -1.6 < 0.01
PRNP prion protein (p27-30) NM_000311 -1.6 < 0.01
PHLDA1 pleckstrin homology-like domain, family A, member 1 AK026181 -1.6 < 0.01
KRT1 keratin 1 NM_006121 -1.5 < 0.01
SEMA5A semaphorin 5A NM_003966 -1.5 < 0.01
* Includes all transcripts with fold difference ≤-1.5 and adjusted P < 0.05. Negative fold difference values indicate higher expression on β7- cells.
Table 3: Surface expression of five gene products on β7+ versus β7- CD4+ T cells
Mean surface protein expression*
Gene Fold difference: Transcript** Fold difference: Surface protein*** CD45RA- β7+ cells CD45RA- β7- cells CD45RA+ cells
LAIR1 +1.7 +2.5 (+1.6 to +3.9) 34.6 15.3 37.3
KLRB1 +1.7 +2.5 (+2.2 to +3.6) 26.1 10.7 1.1
KLRG1 +1.5 1.0 (-3.2 to +2.1) 17.7 15.6 9.1
NT5E +1.3 +1.7 (+1.2 to +3.2) 20.3 11.7 6.8
SELL -1.8 -1.8 (-2.1 to -1.5) 22.8 40.2 50.7
* Mean fluorescence intensity (MFI, in arbitrary units) was measured for 5–8 subjects.** As determined using DNA microarrays. *** Values 
represent mean (range) of the fold difference in MFI between CD45RA- β7+ cells and CD45RA- β7- cells for all subjects. Positive fold difference 
values indicate higher expression on β7+ cells and negative fold difference values indicate higher expression on β7- cells.BMC Immunology 2004, 5:13 http://www.biomedcentral.com/1471-2172/5/13
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expressed on subsets of memory/effector T cells. Memory/
effector cells that lacked L-selectin and CCR7 included a
subset with particularly high β7 expression and a larger
subset with no β7 expression (Fig. 2). CD45RA+ cells that
expressed L-selectin and CCR7 (central memory cells) also
included β7+ and β7- subsets. We found that KLRB1, a
member of the killer cell lectin-like receptor superfamily
also known as CD161 or NKRP1A [29], was highly
expressed on β7+ CCR7- memory effector T helper cells
(Fig. 3). There was less expression on β7- CCR7- memory
effector cells and on CCR7+ central memory cells. KLRB1
was essentially undetectable on CD45RA+ naïve cells. The
expression pattern of NT5E/CD73 was similar, although
NT5E expression was limited to a smaller fraction of cells
than KLRB1 expression (Fig. 4). In contrast, LAIR1 had a
different pattern of expression (Fig. 5). LAIR1 was most
highly expressed on naïve cells, and was also highly
expressed on β7+ CD45RA- cells (both CCR7- and CCR7+
subsets). LAIR1 was less highly expressed on β7- CD45RA-
cells (especially the CCR7- subset). LAIR1 contains two
ITIM domains and can transmit signals following ligation
by antibody, however the nature of the LAIR1 ligand(s)
and the biological function of LAIR1 on CD4+ T cells
remains unknown [30].
Discussion
We used DNA microarrays to identify gene transcripts that
were differentially expressed on the subset of CD4+ mem-
ory/effector T cells that express integrin β7. Since the over-
whelming majority of β7+ cells in blood express the gut
homing receptor integrin α4β7, this approach was
designed to identify genes that might play a role in organ-
specific homing. We identified 16 transcripts that were
more highly expressed in β7+ cells and 18 that were more
highly expressed on β7- cells. We can relate transcript
expression to expression of protein in seven cases (Table 3
and refs. [8,13]). In six of these cases (CCR9, GPR2/
CCR10, KLRB1, LAIR1,  NT5E, and SELL), differential
transcript expression was accompanied by differential
expression of the corresponding protein on the surface of
β7+ versus β7- cells. In one case (KLRG1), we did not find
evidence for a consistent difference in surface protein
expression (Table 3). These data suggest that most of the
differentially expressed transcripts correspond to differen-
tially expressed proteins, although it will be important to
confirm this directly when suitable reagents become
available.
Some of the differentially expressed transcripts encode
proteins with known roles in organ-specific homing. The
A β7high subset of memory/effector T helper cells lacks CD62L and CCR7 Figure 2
A β7high subset of memory/effector T helper cells lacks CD62L and CCR7. Dot density plots depicting expression of 
integrin β7 and (A) SELL (CD62L) or (B) CCR7 on CD4+ CD45RA- T cells. Quadrant lines were drawn based on staining 
obtained with control antibodies.
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two most highly differentially expressed genes we detected
in our analysis encode chemokine receptors already
shown to have important roles in gut and non-gut (skin)
homing. These are CCR9, the TECK/CCL25 receptor
which is expressed preferentially on α4β7+ gut homing
cells [13], and GPR2/CCR10, the CTACK/CCL27 receptor
which is expressed preferentially on CLA+ skin homing
cells [8]. We found that transcripts encoding the α subunit
(ITGA4) of integrin α4β7, was more highly expressed in
β7+ cells. The microarray experiments indicated that the
transcript encoding the β7 subunit itself (ITGB7) was not
differentially expressed, consistent with previous results
obtained using quantitative RT-PCR (M.W.R and D.J.E,
unpublished results). This suggests that surface expression
of the α4β7 heterodimer on CD4+ memory T cells may be
determined primarily by the amount of α4 subunit avail-
able and not by the amount of β7 produced. The other dif-
ferentially expressed transcript with a known role in
homing is SELL, which encodes the peripheral lymph
node homing receptor L-selectin (CD62L). We found that
expression of both L-selectin transcript and surface pro-
tein was higher in β7- than β7+ memory/effector T cells.
Although many β7-expressing memory cells also
expressed L-selectin, cells expressing the highest levels of
β7 did not express L-selectin (Fig. 2). This presumably
contributes to the development of CD4+ T cell subsets
with distinct homing properties.
We also found evidence that β7+ and β7- cells differ in
their expression of other molecules that have been
reported to modulate cell adhesion and migration. KLRB1
transcript and surface protein expression was higher on
β7+ memory effector T cells. Overexpression of KLRB1
(also known as CD161 or NKRP1A) was previously found
to increase transendothelial migration of CD4+ T cells,
perhaps by modulating integrin activity [31]. The finding
that KLRB1 was preferentially expressed on T cells from
human intestine led to a recent suggestion that KLRB1
may help direct intestinal homing [32]. This hypothesis
remains to be tested, but would be consistent with our
finding of preferential expression of KLRB1 on β7+ blood
memory CD4+ T cells. We also found higher expression of
Expression of KLRB1 (CD161) on T helper cell subsets Figure 3
Expression of KLRB1 (CD161) on T helper cell subsets. Histograms depict expression of KLRB1 (CD161) on (A) 
CD45RA+ naïve cells and (B) four subsets of CD45RA- memory/effector cells. These subsets were distinguished by their 
expression of β7 and CCR7, a marker for central memory cells, as shown in Fig. 2B. Black lines indicate KLRB1 staining and 
filled red lines indicate staining obtained with an isotype control antibody.
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NT5E (CD73) transcripts and surface protein on β7+
memory effector T cells. NT5E is an ecto 5'-nucleotidase
expressed on lymphocytes and on endothelial cells and
has been reported to mediate lymphocyte-endothelial
adhesion and transmigration by various mechanisms,
including promotion of integrin-mediated binding via
effects on integrin clustering [33-36]. Transcripts encod-
ing two members of the galectin family were differentially
expressed on β7+ versus β7- cells. Both LGALS1/galectin-1
(expressed at higher levels in β7- cells) and LGALS2/galec-
tin-2 (expressed at higher levels in β7+ cells) have been
shown to have several effects on cell adhesion in lym-
phocytes and other cells [37]. Transcripts for RGS1 were
expressed at higher levels in β7- cells. RGS1 is a GTPase
activating protein that regulates Gαi-stimulated pathways.
Expression of RGS1 inhibits chemokine-induced cell
migration and integrin-mediated adhesion in lym-
phocytes [38]. Our data suggest that there may be less
RGS1-mediated inhibition of chemokine signaling in β7+
cells. We speculate that the differential expression of
KLRB1, NT5E, LGALS1, LGALS2, and RGS1 on β7+ and β7-
T helper cell subsets may contribute to homing specificity
by modulating the complex multistep process of cell
adhesion and migration.
The primary activation of T cells leads to changes in the
expression of integrin α4β7 and other molecules that con-
trol homing. It has recently been shown that upregulation
of integrin α4β7 expression and increased responsiveness
to the CCR9 ligand TECK occur within two days after acti-
vation of murine naïve CD4+ T cells in intestinal, but not
cutaneous, lymph nodes [18] and that activation by den-
dritic cells from Peyer's patches but not peripheral lymph
node or spleen promotes murine CD8+ T cell α4β7 expres-
sion and TECK responsiveness [19]. We found that both
KLRB1 and NT5E were virtually absent on CD45RA+ naïve
CD4+ T cells and were expressed at low levels on CD45RA-
CCR7+ central memory cells and on β7- CD45RA- non-gut
homing memory effector cells but were expressed at
higher levels in the β7high CCR7- CD45RA- memory effec-
tor subset. In contrast, LAIR1 was highly expressed on
naïve T cells and on both CCR7- and CCR7+ β7+ CD45RA-
Expression of NT5E (CD73) on T helper cell subsets Figure 4
Expression of NT5E (CD73) on T helper cell subsets. Histograms depict expression of NT5E (CD73) on (A) CD45RA+ 
naïve cells and (B) four subsets of CD45RA- memory/effector cells. These subsets were distinguished by their expression of β7 
and CCR7, a marker for central memory cells, as shown in Fig. 2B. Black lines indicate NT5E staining and filled red lines indi-
cate staining obtained with an isotype control antibody.
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cells but expression was lower on β7- CD45RA- cells. These
results suggest that expression of α4β7 and expression of
KLRB1, NT5E and LAIR1 may be coordinately regulated at
the time of human T cell activation, as is apparently the
case for α4β7 and CCR9 in mouse systems. Alternatively,
it is possible that differences in expression arise from
changes in gene expression that occur after the transition
from naïve to memory effector cells or from the
preferential retention of survival of particular memory
effector cell subsets. Although we showed that expression
of KLRB1, NT5E and LAIR1 was higher for the β7+ subset
as a whole, many β7+ cells did not express these proteins
and some β7- cells did. This suggests that the homing
properties of individual T cells might be "fine tuned" by
complex combinatorial regulation of molecules known to
have major roles in determining organ-specific recruit-
ment (e.g., integrin α4β7 and CCR9) and other molecules
that can modulate adhesion and migration (e.g., KLRB1
and NT5E).
Conclusions
We used DNA microarrays to identify a set of gene tran-
scripts that were differentially expressed on β7+ versus β7-
blood memory CD4+  T cells. Some of these encode
adhesion receptors (integrin α4 and L-selectin) and chem-
okine receptors (CCR9 and GPR2/CCR10) already known
to be involved in organ-specific lymphocyte migration.
Other differentially expressed transcripts encode addi-
tional molecules previously reported to affect cell adhe-
sion and migration, including KLRB1, NT5E/CD73,
LGALS1 and LGALS2 (galectin-1 and -2) and RGS1. As
predicted from the transcript expression data, we found
that KLRB1, NT5E and LAIR1 proteins were all preferen-
tially expressed on the surface of β7+ versus β7- memory
CD4+ T cells. Our results suggest that expression of several
molecules that can modify T cell adhesion, endothelial
transmigration and chemotaxis are also selectively regu-
lated on CD4+ T cell subsets, perhaps during the "imprint-
ing" process that takes place during initial T cell
activation. These molecules are likely to contribute to the
complex multistep process that regulates trafficking of
Expression of LAIR1 on T helper cell subsets Figure 5
Expression of LAIR1 on T helper cell subsets. Histograms depict expression of LAIR1 on (A) CD45RA+ naïve cells and 
(B) four subsets of CD45RA- memory/effector cells. These subsets were distinguished by their expression of β7 and CCR7, a 
marker for central memory cells, as shown in Fig. 2B. Black lines indicate LAIR1 staining and filled red lines indicate staining 
obtained with an isotype control antibody.
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CD4+  memory T cell subsets with different homing
behaviors.
Methods
Isolation of β7+ and β7- lymphocytes from human blood
This protocol was approved by the Committee on Human
Research at the University of California, San Francisco and
informed consent was obtained from all subjects. Periph-
eral blood mononuclear cells (PBMC) were isolated from
nine normal adult donors (six females and three males,
ages 24–42 years) using sodium heparin coated
Vacutainer Cell Preparation Tubes (Becton Dickinson)
according to the manufacturer's instructions. PBMC were
stained with CD4-FITC, CD45RA-Cy5 and anti-integrin
β7-PE (all from BD Pharmingen). Anti-FITC microbeads
and a MACS bead sorter (Miltenyi Biotec) were used to
enrich for the CD4+ cells prior to flow cytometry. CD4+
memory (CD45RA- ) β7+ and β7- T cells were then purified
using a FACS Vantage (Becton Dickinson).
Microarray analysis of transcript expression
Total RNA from β7+ and β7- CD4+ memory T cells was
purified using the Mini RNA Isolation Kit (Zymo
Research) and DNase treated using the DNA-free RNA Kit
(Zymo Research) according to the manufacturer's instruc-
tions. RNA quality was evaluated using an Agilent Bioan-
alyzer. RNA amplification, labeling, and hybridization
were performed as previously described with slight modi-
fications [27]. In brief, two rounds of amplification were
performed using T7 RNA polymerase (Ambion Mes-
sageAmp aRNA Kit). Cy3 or Cy5 was incorporated into
the amplified RNA products using amino allyl-modified
nucleotides. Fluorescently-labeled amplified RNAs were
fragmented using Ambion RNA Fragmentation Reagents
and hybridized to DNA microarrays using Ambion Slide-
Hyb Glass Array Hybridization Buffer #1. Each hybridiza-
tion involved β7+ cell RNA from a single subject (labeled
with one dye) and β7- cell RNA from the same subject
(labeled with the other dye). A total of 27 arrays were used
to analyze samples from the 9 subjects (at least 2 arrays
per subject, including a dye swap).
Arrays were produced in our microarray facility using the
Operon version 2 set of 70-mer oligonucleotide probes
supplemented with some custom-designed 70-mers as
described [27]. Arrays included probes for 21357 genes
plus control probes. After hybridization, arrays were
scanned using an Axon GenePix 4000B scanner and
images were processed using GenePix 5.0 software. The
"print-tip loess" normalization was used to correct for
within-array dye and spatial effects [39] and single chan-
nel quantile normalization was used to facilitate compar-
ison between arrays [40]. We used functions in the library
marrayNorm [41] of the R / Bioconductor package [42] to
perform these normalizations. After normalization we
determined a log ratio, log2 (β7+ sample intensity/β7- sam-
ple intensity), for each probe on each array. No back-
ground subtraction was performed. Complete
information about the array platform and data from each
of the individual arrays is available from GEO [43] (GEO
accession GSE1039). Appendix 1 [see additional file 1] is
a MIAME-compliant description of the array experiments.
Identification of differentially expressed gene transcripts
A fixed effects linear model was used to estimate differ-
ences in transcript expression between β7+ and β7- CD4+ T
cells. For each individual gene (probe) on the array, the
model can be described as
Y ij = µ + A i + εij ,
where Y ij represents the normalized log ratio determined
on a single array, i represents the subject number and j
represents the array number. The parameter µ represents
the actual log ratio of gene expression between β7+ and β7-
cells, which we wished to estimate. A i represents the dif-
ference between the log ratio for subject i and the average
log ratio for all subjects and ε denotes the experimental
error. We fit the model using a zero sum constraint (ΣA i
= 0). Fold difference was calculated from the estimated log
ratio. We computed moderated t-statistics [44], log-odds
ratios of differential expression (based on empirical Bayes
shrinkage of the standard errors towards a common value
[45]), and adjusted p-values (obtained using the Bonfer-
roni correction) using functions in the limma library of
the Bioconductor software package [41,42]. Similar
results were obtained under a random effects model (not
shown).
Analysis of surface protein expression on blood CD4+ T cell 
subsets
Whole blood was collected from nine normal adult sub-
jects (seven females and two males, ages 23–38 years,
none of whom were included in the microarray experi-
ments described above). Blood was stained with various
antibody combinations and analyzed on a FACScalibur
equipped for six color analysis. Antibodies recognizing
CD4 (SK3), integrin β7 (FIB504), CD62L (DREG-56),
CD73 (AD2), and CD161 (DX12) and isotype control
antibodies were all from BD Biosciences. Other antibod-
ies used were LAIR1 (DX26, generous gift of L. Lanier),
KLRG1 (13A2, generous gift of D. Voehringer and H.
Pircher), CD45RA (Immunotech), the anti-α4β7 mAb
Act-1 [46], the anti-aEβ7 antibody HML-1 (Beckman
Coulter), CCR7 (R&D Systems). Mean fluorescence inten-
sity (MFI) was corrected by subtracting the MFI obtained
with isotype control antibodies. The percentage of posi-
tive cells was determined by setting the threshold so that
≤1% of cells were considered positive after staining with
control antibody.BMC Immunology 2004, 5:13 http://www.biomedcentral.com/1471-2172/5/13
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